Lataa...
Mutant p53–Nrf2 axis regulates the proteasome machinery in cancer
The proteasome machinery is a common target of gain-of-function p53 missense mutants. Upregulation of the proteasome fosters chemoresistance to proteasome inhibitors. In triple negative breast cancer cells this resistance mechanism, namely the Nrf2-regulated “bounce-back” response to proteasome inhi...
Tallennettuna:
| Julkaisussa: | Mol Cell Oncol |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Taylor & Francis
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5286961/ https://ncbi.nlm.nih.gov/pubmed/28197530 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/23723556.2016.1217967 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|